We're sorry, but we couldn't find any results that match your search criteria. Please try again with different keywords or filters.
Loading
-
PlymouthFinding new therapies for brain diseases requires preclinical models and assays with increased clinical relevance. a:head aims to develop a human-based platform for generating complex brain-like tissu ...
-
UrisActithera is an early-stage radiotherapeutics company with a platform for the design of Theranostics with prolonged tumor retention and rapid peripheral clearance. Its approaches have been validated i ...
-
RoyaleAntibodies have become the top-selling class of therapeutics stemming from their high level of specificity and affinity for disease proteins as well as their ability to target diverse molecules with a ...
-
RoyaleAileron is developing novel medicines to provide better treatment options for patients with life-threatening pulmonary conditions. With its acquisition of Lung Therapeutics, Aileron is shifting its di ...
-
UrisAIVITA Biomedical is a biotechnology company developing personalized vaccines for the prevention of infectious disease and treatment of cancer. We take a unique pan-antigenic approach for our cancer v ...
-
PlymouthReversing osteoarthritis. Introducing an unprecedented category innovation in nanotechnology to fully restore the joint function in osteoarthritic patients, with impeccable results paving the way to c ...
-
UrisAlligator Bioscience is a clinical-stage biotech company developing agonistic antibody-based pharmaceuticals for tumour-directed immunotherapy of cancer. Our lead asset, mitazalimab, a second generati ...
-
RoyaleAllyx Therapeutics was founded in 2019 by a group of seasoned biopharma industry executives, venture capitalists, and scientific experts. The company aims to deliver a novel approach to preserve and p ...
-
PlymouthAlphyn is developing first-in-class Multi-Target Therapeutics® for severe and prevalent skin diseases based on its AB-101 platform, which has multiple bioactive compounds and, therefore, multiple mech ...
-
UrisApricity Health is a precision oncology company at the intersection of digital health, AI and biotechnology. It pioneers Dynamic Precision™, which mines longitudinal clinical and molecular data from p ...
-
PlymouthAshvattha is a clinical stage company with a transformative nanomedicine technology exclusively licensed from Johns Hopkins University. The nanomedicine, hydroxyl dendrimers (HDs), precisely targets r ...
-
UrisAt Avstera, our primary initial focus is to address the significant unmet need of advanced cancer patients who have limited or no treatment options. These include patients who fail to respond to exist ...
-
PlymouthAyuVis is pioneering novel small molecule immunotherapies to prevent/treat inflammatory and infectious diseases based on a platform technology of macrophage modulation for a balanced immune response. ...
-
UrisBexion Pharmaceuticals is a mid-clinical stage biotechnology company developing biologics for the treatment of solid tumor cancers and chemotherapy-induced peripheral neuropathy (CIPN). Our lead asset ...
-
UrisBiograil is developing the proprietary technology BIONDD(TM) capsule delivering biologic drugs with a bioavailability like SC injection creating a broad platform for oral delivery of drugs that would ...
-
RoyaleBioHarvest Sciences has developed a patented Botanical Synthesis platform technology capable of growing the active and beneficial plant-based compounds, at an industrial scale, without the need to gro ...
-
UrisBioInvent International AB (Nasdaq Stockholm: BINV) is a clinical-stage biotech company that discovers and develops novel and first-in-class immuno-modulatory antibodies for cancer therapy, with curre ...
-
PlymouthBionomics, a publicly listed clinical late-stage company focused on addressing unmet needs in CNS. We are developing BNC-210, a Ph3-Ready First- and-Best-in-Class α-7 Nicotinic Receptor for the Treatm ...
-
PlymouthBRINTER, a first-mover US medical technology firm with 3D bioprinted universal human cartilage platform (BioMods™) for the $10B+ cartilage repair market. Our first 510(k) Nose-BioMod™ product is estim ...
-
PlymouthCaledon Biosciences is a privately held, start-up founded in October 2023. Caledon owns the key assets, management and operations of a former NASDAQ listed entity, Liminal BioSciences Inc, which was r ...
-
PlymouthCalissa Therapeutics is a clinical stage dermatology company targeting vascular lesions. Our lead indications are rosacea and port wine birthmark, one of the most common birthmarks. Lead asset CX-001 ...
-
UrisCandel is a clinical stage biopharmaceutical company focused on developing off-the-shelf multimodal biological immunotherapies that elicit an individualized, systemic anti-tumor immune response to hel ...
-
UrisCarina Biotech is a clinical stage immuno-oncology company developing CAR-T and other adoptive cell therapies for the treatment of solid cancers. In addition to its LGR5-targeted CAR-T cell therapy CN ...
-
PlymouthA Clinical-stage Biotech Company Developing ‘Off-the-shelf’ Non-gene Modified Hematopoietic Stem Cells & Its Derived Immune Cell Therapies For Cancer Patients.
-
RoyaleCervoMed is a clinical stage company targeting synaptic dysfunction to treat age-related neurologic disorders. The Company is currently developing neflamapimod, an oral small molecule brain penetrant ...
-
UrisChimeric Therapeutics, is a clinical stage cell therapy company focused on bringing the promise of cell therapy to life for more patients with cancer. Chimeric is developing two first in class autolog ...
-
UrisCitius Pharma is a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunc ...
-
PlymouthCoastar Therapeutics is a venture-backed biotech company based in San Diego, CA, focused on next generation gene delivery technology. The company has developed a novel ENHEnS application that can coat ...
-
RoyaleCognigenics is a privately held pre-clinical neuro-engineering company pioneering the frontier of RNA based therapeutics and focused on developing and commercializing innovative genetic medicines to t ...
-
UrisConcerto Biosciences creates breakthrough microbe-based products originating from our unmatched understanding of microbial ecology. Microbes in, on, and around us work in concert to improve human heal ...
-
UrisCyclacel is a clinical-stage biopharmaceutical company developing innovative cancer medicines based on cell cycle, transcriptional regulation, epigenetics and mitosis biology. The transcriptional regu ...
-
UrisCyGenica, a pioneering biotech startup, revolutionises intracellular therapeutics development through their drug delivery platform, GEENIE, which promises to redefine the landscape of pharmaceutical t ...
-
UrisCytovation is a clinical-stage oncology biotech focused on the development of CyPep-1, a first-in-class synthetic peptide designed to drive a systemic anti-cancer immune response, with a unique dual m ...
-
UrisClinical Efficacy in the Toughest Cancers -- Cracking the Code on Dendritic Cell Therapy and Tumor Infiltrating Lymphocytes Diakonos Oncology is developing two cell therapy technologies developed at M ...
-
RoyaleDiamyd Medical is a Stockholm-based, precision medicine company developing an antigen-specific immunotherapy for the treatment and prevention of (autoimmune) Type 1 Diabetes in a genetically defined r ...
-
PlymouthEditpep produces CRISPR based therapeutics by leveraging the Transporter peptide based delivery platform, focusing on CNS and eye indications.
-
PlymouthEG 427 develops a unique vector platform to deliver pinpoint neurotherapeutics to treat prevalent diseases of the peripheral and central nervous system. Our vectors can achieve focal transduction in s ...
-
PlymouthElsie Bio is focused on applying medicinal chemistry to oligonucleotide development. We use DNA encoded technology to design and develop optimal RNA therapeutics. Our approach is redefining how we tre ...
-
PlymouthEosDx is creating a new modality for AI-driven cancer detection using Bio-crystallography that identifies cancer biomarkers in tissue using a non-invasive, safe, accurate, and objective test
-
PlymouthEpion Therapeutics is developing a minimally invasive treatment for keratoconus that can bring early intervention to millions of patients globally. Our EpiSmart approach is a transformative cross-link ...
-
RoyaleEVast Bio is a US-based, clinical-stage biotech born as a result of ground-breaking work at C4C (https://c4c.cl). EVast Bio is devoted to exploring the vast potential of small Extracellular Vesicles ( ...
-
PlymouthFirst Wave BioPharma is a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The Company is currently adva ...
-
PlymouthGaruda’s mission is to bring curative blood stem cell therapy to patients worldwide suffering from serious diseases, while eliminating the dependency on donor or patient cells for transplants. Garuda’ ...
-
PlymouthGenEndeavor is a molecular diagnostics technology company on a mission to prevent genetic and infectious diseases by quickly and accurately detecting pathological biomarkers in early stages.
-
UrisCelebrating its 20th anniversary, Genesis Healthcare is Japan’s leading genetic testing and research company, servicing medical institutions, government, corporations, and individuals to benefit from ...
-
PlymouthGenprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fi ...
-
RoyaleGentas' mission is to bridge BioPharma’s translational gap by providing preclinical testing services using miniature swine models. Gentas will dramatically improve the success rate for testing by 1) i ...
-
RoyaleGeoVax is developing novel therapies and vaccines for solid tumor cancers and infectious diseases. The company’s lead program in oncology is a novel oncolytic solid tumor gene-directed therapy, Gedept ...
-
PlymouthHalia is a clinical-stage biopharmaceutical company discovering and developing novel therapies to improve the lives of patients with inflammatory disorders and neurological diseases. We do this by adv ...
-
RoyaleHumanetics is a privately held, clinical stage pharmaceutical company located in the Minneapolis metropolitan area. Humanetics entered the field of radiation modulators through a cooperative research ...
-
UrisImmuneOnco is a HongKong stock exchange-listed, clinical stage biotech company focused on discovering and developing immunotherapies to treat cancer. The most advanced clinical program is timdarpacept ...
-
PlymouthImmunis is a private biotechnology company researching and developing secretome products to address age-driven immune deficits. Immunis has developed a novel method to grow human cells for clinical us ...
-
RoyaleIN8bio, a clinical-stage biopharmaceutical company, focuses on gamma-delta T cell product candidates for solid and liquid tumors. These T cells, naturally differentiating between healthy and diseased ...
-
UrisIndaptus Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. The company develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate is Decoy ...
-
RoyaleInimmune is a private clinical stage company dedicated to developing immuno-therapeutics. It is focused on advancing its Toll Like Receptor ligand portfolio as immunotherapeutics and vaccine adjuvants ...
-
UrisInnova Therapeutics is a Charleston, South Carolina based biotechnology company developing a monoclonal antibody (mAb) platform targeting a protein, secreted frizzled related protein 2 (SFFRP2), that ...
-
UrisIntensity Therapeutics, Inc. is a late-stage clinical biotechnology company focused on the discovery and development of proprietary, novel immune-based intratumoral cancer therapies designed to kill t ...
-
UrisAt Intrepid Labs, we're pioneering the future of drug development through advanced AI, robotics, and drug formulation science. Our mission is to enhance patient care by making treatments more personal ...
-
PlymouthIVIEW Therapeutics Inc. is a clinical-stage ophthalmology-focused therapeutics company based in Cranbury, New Jersey committed to the treatment of ocular diseases with high unmet medical needs through ...
-
PlymouthJaguar Health is a commercial stage pharmaceuticals company focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals ...
-
PlymouthJan Biotech, Inc. has developed a disruptive RNA detection technology that provides unprecedented prediction accuracy (0.97) for time to rebound for antiretroviral treated HIV-infected individuals and ...
-
PlymouthKanglin Biotechnology (Hangzhou) Co., Ltd. was founded in 2015 with the goal of translating advances in genetic science into curative treatments for previously incurable diseases. We believe in the gr ...
-
UrisKernal Bio is a biotech company developing mRNA 2.0 immunotherapies. Kernal mines translatome data to discover cell-specific sequence features and design mRNAs that are selectively translated in cance ...
-
UrisLarkspur Biosciences is pioneering a new wave of cancer therapy by developing medicines that target immune evasion where it starts – in the cancer. Our integrated discovery and translational approach ...
-
UrisLeapfrog Bio is a seed stage company focused on developing precision therapeutics targeting solid tumors caused by loss of function mutations. Since inception in 2019 the company has developed and val ...
-
UrisLikarda has pioneered a groundbreaking platform for hydrogel delivery systems, offering both long- and short-term solutions that can either provide complete immuno-protection or degrade gradually. Thi ...
-
UrisLisata Therapeutics is a clinical-stage pharmaceutical company dedicated to the discovery, development and commercialization of innovative therapies for the treatment of advanced solid tumors and othe ...
-
UrisLuminary stands out as a clinical stage CAR-T therapy company utilizing a unique allogeneic manufacturing platform. Our CAR and TCR development revolve around gamma delta cells, giving our allogeneic ...
-
RoyaleLyndra Therapeutics is a clinical-stage biopharmaceutical company pioneering long-acting oral therapies. Lyndra’s LYNX® drug delivery platform is one of the most significant advances in oral drug deli ...
-
PlymouthMercy BioAnalytics is a pre-commercial diagnostics company on a mission to save lives and relieve suffering through the early detection of cancer. We are developing ,broadly accessible, inexpensive, b ...
-
UrisMERLIN Biotech is a pre-clinical stage mRNA platform company with a novel 1st in class cancer immunotherapy with exclusive IP in major worldwide markets. Our target, USP6, has demonstrated invivo effi ...
-
PlymouthNanoscope Therapeutics is a clinical-stage biopharmaceutical company developing gene therapies to cure genetic diseases that cause vision impairment and blindness.
-
PlymouthNavega Therapeutics' mission is to develop durable relief for chronic and complex diseases, via DNA gene regulation. The company’s technology is centered around a ZF-AI, a proprietary deep learning al ...
-
PlymouthNeurocentrx is seeking the 1st FDA approval of an abuse-deterrent oral ketamine therapy for depression suitable for clinical and home administration. The company is Phase 3 ready, with a patent abuse- ...
-
PlymouthA new brain liquid biopsy - Neuron Derived Exosomes, their use, and their promise in disease stratification.
-
PlymouthNewron (SIX: NWRN, XETRA: NP5) is a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system. The Company is head ...
-
UrisNobias Therapeutics is a biotechnology company pioneering deep phenotyping to discover advanced therapeutics. Nobias uses its cutting-edge, applied AI platform to distill disease drivers and optimal p ...
-
RoyaleNRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal bipola ...
-
PlymouthOcugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the gl ...
-
PlymouthOcuphire Pharma is a late clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of retinal and refractive eye disorders.
-
UrisOncoteq is a clinical stage oncology biotech with a focus on first or best-in-class treatments in areas of high unmet need. The company portfolio comprises two highly differentiated assets. TEQ103 has ...
-
PlymouthONL Therapeutics (ONL) is a clinical-stage biopharmaceutical company committed to protecting and improving the vision of patients with retinal disease. By advancing a breakthrough technology designed ...
-
UrisPanavance Therapeutics Inc. is a privately held, clinical-stage pharmaceutical company developing a novel oncology asset, misetionamide (known as GP-2250). Panavance was formed in 2021 as a carve out ...
-
PlymouthPapillon Therapeutics is advancing gene therapy treatments for life threatening conditions with neurologic disease, including Friedreich's ataxia, Danon disease, and Alzheimer’s disease. We specialize ...
-
UrisPortal Instruments is a clinical-stage drug delivery and digital health company transforming injectable biologics into 21st century therapies that are needle-free and seamlessly cloud-connected. Porta ...
-
UrisPredictive Oncology is a science-driven company leveraging its proprietary artificial intelligence (AI) and machine learning capabilities, a proprietary, extensive biorepository of tumor samples, Clin ...
-
UrisProcessa Pharmaceuticals is a clinical stage pharmaceutical company developing Next Generation Chemotherapies (NGCs) to address the underlying challenges of current drugs by modifying pharmacokinetics ...
-
PlymouthProMIS Neurosciences (Nasdaq:PMN) is a Cambridge, Massachusetts and Toronto, Ontario-based clinical stage biotechnology company committed to the discovery and development of therapeutic antibodies sel ...
-
PlymouthProtalix is a commercial-stage biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins expressed through its proprietary plant cell-based express ...
-
PlymouthPTM Therapeutics is a pre-clinical stage antibody therapeutics company developing therapies through targeting post-translational modifications for the treatment of inflammatory bowel disease and solid ...
-
UrisRakuten Medical, Inc. is a global biotechnology company developing precision, cell-targeting investigational therapies on its Alluminox™ technology platform which, in pre-clinical studies have been sh ...
-
UrisReglagene is revolutionizing brain disease therapy by targeting tubulin with a groundbreaking class of selective inhibitors. Our novel compounds, led by RGN6024, offer a blend of oral administration, ...
-
Uristbc
-
PlymouthRejuvenation Technologies in developing therapeutics to extend telomeres to combat diseases of aging.
-
PlymouthPioneering marcrophage cell therapy to transform the outcomes of patients with End Stage Liver Disease
-
RoyaleRevelation Biosciences, Inc. is a life sciences company focused on harnessing the power of trained immunity for the prevention and treatment of disease using its proprietary formulation Gemini. Revela ...
-
RoyaleReviva is a late-stage biopharmaceutical company that discovers, develops, and seeks to commercialize next-generation therapeutics for diseases representing unmet medical needs and burdens to society, ...
-
RoyaleAt this meeting, we will present "Losing Fat Mass without Impacting Muscle Mass: A New Approach for Weight Loss". Ridgeline is developing transformative oral drugs for the multi-billion obesity and mu ...
-
RoyaleSAB Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing fully-human, multi-targeted, high-potency immunoglobulins (IgGs), without the need for human donors or convalesc ...
-
PlymouthSaghmos Therapeutics is developing ST-62516 to reduce the risk of Acute Kidney Injury (AKI) and Major Adverse Cardiac and Kidney Events (MACKE) after contrast procedures such as percutaneous coronary ...
-
UrisSapience Therapeutics, Inc. is a privately held, clinical-stage biotechnology company focused on discovering and developing peptide therapeutics to address oncogenic and immune dysregulation that driv ...
-
UrisSatellite Bio is a well-funded regenerative medicine company with cutting-edge hepatocyte technologies designed to tackle a broad range of liver diseases. Our platform encompasses a proprietary primar ...
-
RoyaleScenic Biotech is a biopharmaceutical company advancing modifier therapy, a radically new approach to treating genetic disorders. Instead of targeting the primary disease-causing mutation, modifier th ...
-
UrisSciTech is a clinical-stage oncology-focused drug delivery technology company. Our initial clinical trial is underway with IRB-approved sites at UPMC, Columbia University, MD Anderson, USC, U Michigan ...
-
PlymouthSeek Labs is developing next generation molecular diagnostics technologies that have the potential to revolutionize the detection and treatment of diseases. Point of care diagnostics is currently limi ...
-
UrisSeraGene Therapeutics is a pre-clinical stage company using RNA and nanomedicine technology to provide long lasting, targeted control for coagulation disorders. Leveraging a deep understanding of clot ...
-
PlymouthSernova is a clinical-stage biotechnology company that is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and hemophilia A. The Co ...
-
PlymouthSIRPant Immunotherapeutics, Inc., a clinical stage company, programs the cells that drive immunity – macrophages – to mobilize effective polyclonal anti-cancer immune responses, providing a novel mult ...
-
UrisStarton is a clinical-stage biotechnology company transforming standard of care therapies with proprietary continuous delivery technology, so people with cancer can receive continuous treatment to liv ...
-
RoyaleSupernova Bio is a R&D-focused bio-venture that has developed therapeutic agents for lipolysis, anti-lipoma, and liposarcoma by utilizing gas-generating polymer nanoparticles that significantly reduce ...
-
PlymouthSustained Therapeutics is a clinical stage company utilizing advanced clinical and research expertise to develop a patented novel locally injected sustained-release drug delivery platform. This platfo ...
-
UrisTactical Therapeutics, Inc is a clinical stage private Co in New York, developing Carboxyamidotriazole orotate (CTO) which has shown safety and efficacy in primary brain cancer and many undruggable he ...
-
RoyaleTonix is a biopharmaceutical company commercializing, developing, discovering and licensing therapeutics to treat and prevent human disease and alleviate suffering. Tonix’s development portfolio is fo ...
-
RoyaleUvax Bio is a clinical stage, privately funded biotechnology company focused on developing vaccines to address unmet clinical needs in the prevention of infectious diseases. Uvax Bio holds the exclusi ...
-
RoyaleVasomune Therapeutics Inc., is a clinical stage biopharma, with an asset in mid-phase 2a. AV-001, is a Tie-2 agonist that corrects vascular endothelial dysfunction and shows strong activity against li ...
-
UrisVerImmune Inc is developing a highly innovative Virus-inspired Particle (ViP™) platform technology that has the potential to treat multiple diseases, with an initial focus on Oncology.
-
UrisVincogen corporation (www.vincogen.com) is the Biotechnology - Artificial Intelligence company and has developed VincoAI, a collection of generative AI models. VincoAI is the first proof-of-concept ge ...
-
RoyaleZiphius is a biotechnology company focused on the development of self-amplifying RNA-based (saRNA) vaccines and therapeutics based on its proprietary saRNA and carrier technology (LNP) platform to all ...
-
UrisZTI BIOSCIENCES specializes in the development of radiopharmaceuticals for cancer therapeutics based on the Nano-tech platform (TERACARRIER™), distinguished as the world's first and only technology. [ ...
-
RoyaleZWI Therapeutics is a US biotechnology company developing novel protein therapeutics linked to a novel polymer. The company’s new proprietary polymer shows improved pharmacokinetics and reduced potent ...
-
RoyaleZyVersa is a clinical stage specialty biopharmaceutical company leveraging advanced, proprietary technologies to develop first-in-class drugs. Our focus is on patients with renal or inflammatory disea ...
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}
)
)
)
){kind=logo}